Indications
Ofev is indicated in adults for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
Composition
- Active substance
- nintedanib
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Ofev
- Active substance
- nintedanib
- ATC code
- L01EX09
- Therapeutic area
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial, Pulmonary Fibrosis, Scleroderma, Systemic
- Marketing authorisation holder
- Boehringer Ingelheim International GmbH
- Status
- Authorised
- EU authorisation